Skip to content

Evaluation of Urine Samples and Their Relation to Urinary Tract Infection

Evaluation of Urine Samples and Their Relation to Urinary Tract Infection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03522766
Enrollment
30
Registered
2018-05-11
Start date
2018-03-19
Completion date
2019-09-23
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Brief summary

The aim is to explore the human urine composition and its relation to urine tract infections

Interventions

OTHERurine sample

The subjects are asked to give a maximum of 15 urine samples during the study

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Have given written informed consent 2. Be at least 18 years of age and have full legal capacity 3. For the 2 patient populations: Use intermittent catheter on a daily basis due to neurogenic bladder or enlarged prostate and have used IC for at least 2 months 4. For healthy volunteers without UTIs: No diag-nosed UTIs within the last year 5. For healthy volunteers with recurrent UTIs: 3 or more UTIs within the last year or 2 UTIs within the last 6 months (treated with antibiotics)

Exclusion criteria

1. Be treated for urinary tract infection at time of enrolment 2. May not take prophylactic treatment for urinary tract infections (antibiotics only)

Design outcomes

Primary

MeasureTime frameDescription
Type of bacteria present in the urine1 yearThe different bacteria isolated present in the urine will be identified

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026